Patient Data. Exhibits Click to specify whether the client statements following asthma management education indicate understanding or no understanding. Each row must have one option selected.

Rationale: Fluticasone has the same risk as oral steroids: Inhaled corticosteroids primarily target local airway inflammation with minimal systemic absorption. Oral corticosteroids, in contrast, carry higher risks such as adrenal suppression, osteoporosis, and glucose intolerance. Reduce allergen exposure: Environmental allergens such as dust, pollen, and mold are major asthma triggers that promote airway inflammation. Reducing exposure minimizes bronchospasm risk and helps prevent acute exacerbations, aligning with standard asthma self-management guidelines. Maintain normal activity levels: Well-controlled asthma should not limit a patient’s ability to exercise or engage in daily activities. The goal of therapy is to reduce symptoms, improve lung function, and maintain quality of life rather than impose long-term physical restrictions. Other drug options available: Asthma management follows a stepwise approach. If inhaled corticosteroids like fluticasone are insufficient, the provider may add long-acting beta-agonists, leukotriene modifiers, or biologics. Peak expiratory flow monitoring: Daily monitoring allows early detection of airflow limitation before symptoms appear. Declining values may indicate worsening control or an impending exacerbation, prompting early intervention to avoid hospitalization. Discontinue albuterol once fluticasone is prescribed: Fluticasone is a maintenance controller medication that reduces airway inflammation over time, but it does not provide immediate bronchodilation. Albuterol remains necessary as a rescue inhaler for acute symptoms and should never be discontinued unless otherwise directed.